Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Sixty-seven percent of healthcare system leaders are “very or extremely” concerned about Medicaid and Medicare reimbursement impacts and potential disruption to hospital operations, with 61% expect | If potential reimbursement cuts exceed 10%, respondents say it will have negative impacts on staffing decisions and technological investments.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

The number of health services deals dipped in the first half of 2026 but deal value "remained resilient" as strategic acquirers…

Patient collections are playing a bigger and bigger role in health systems’ total revenues, bringing a new focus on the…

Just hours after the Trump administration announced action against fraud in the hospice and home health spaces, Vice President JD…

As healthcare costs continue to rise, smaller businesses are particularly vulnerable to the pressure, according to a ne | As…

Fewer than a third of people with commercial coverage say that their plans represent a "trusted partner" in their health,…

More than 500 hospitals falling short on price transparency requirements have received warnings from the federal government since…